Johnson & Johnson MedTech (NYSE: JNJ) recently announced significant regulatory milestones for its orthopedic technology offerings, marking advancements in the field. The company revealed that its VOLT system has received the CE mark, while the Inhance Intact system has secured FDA 510(k) clearance. These innovative technologies, among others, were showcased at the American Academy of Orthopaedic Surgeons (AAOS) 2025 Annual Meeting held in San Diego.
The VOLT system, described as a variable angle optimized locking technology, incorporates dynamic compression with variable angle locking. This is achieved without compromising stability within a plating system. The company launched VOLT in the United States last fall and is planning a European rollout later this year.
Johnson & Johnson MedTech’s Inhance Intact system is a proprietary instrument set designed for use with the Inhance shoulder system. It is utilized in subscapularis-sparing (SCS) total anatomic shoulder replacements. When combined with the TruMatch 3D pre-surgical planning cloud system, the technology enables a highly personalized approach tailored to individual patient anatomy.
In addition to these advancements, Johnson & Johnson MedTech also displayed its Velys robotic-assisted solution, which has received FDA clearance for unicompartmental knee arthroplasty (UKA). Alongside this, the integrated Attune Knee system and the Sigma HP implant were also presented. Further innovation was highlighted by a new platform integrating standalone navigation with cutting-edge active robotic technology for Velys Spine. Other offerings on display included the Kincise surgical automated system, AI-powered Advance Case Management, and wound closure and healing solutions.
“With over 1.7 billion people worldwide living with musculoskeletal conditions—a prevalence that surpasses cancer, heart, and lung diseases combined—the need for impactful and scalable orthopedic solutions is paramount. At AAOS 2025, we are pleased to show how our innovations are transforming the orthopedic procedure ecosystem to meet this rising demand,” stated Aldo Denti, group chair, Orthopaedics, Johnson & Johnson MedTech. “By seamlessly integrating innovative implants with advanced surgical techniques and data-driven enabling technologies, we are supporting surgeons in enhancing patient care while also boosting efficiency for hospitals and ambulatory surgery centers.”
